0001437749-22-015774.txt : 20220623
0001437749-22-015774.hdr.sgml : 20220623
20220623194759
ACCESSION NUMBER: 0001437749-22-015774
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211118
FILED AS OF DATE: 20220623
DATE AS OF CHANGE: 20220623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Diamandis Peter
CENTRAL INDEX KEY: 0001528288
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41058
FILM NUMBER: 221036696
MAIL ADDRESS:
STREET 1: 4640 ADMIRALTY WAY
STREET 2: SUITE 500
CITY: MARINA DEL REY
STATE: CA
ZIP: 90292
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vaxxinity, Inc.
CENTRAL INDEX KEY: 0001851657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 862083865
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
BUSINESS PHONE: (254) 244-5739
MAIL ADDRESS:
STREET 1: 1717 MAIN STREET
STREET 2: SUITE 3388
CITY: DALLAS
STATE: TX
ZIP: 75201
4/A
1
rdgdoc.xml
FORM 4/A
X0306
4/A
2021-11-18
2021-11-18
0001851657
Vaxxinity, Inc.
VAXX
0001528288
Diamandis Peter
1717 MAIN STREET
SUITE 3388
DALLAS
TX
75201
1
Class A common stock
2021-11-18
4
S
0
248
13
D
90499
D
In the Form 4 filed on November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction.
On November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction.
/s/ Rene Paula Molina, attorney-in-fact for Peter Diamandis
2022-06-23